Lifecore Biomedical, Inc. \de\ SEC filings LFCR
Lifecore Biomedical, Inc. \de\ has 1,005 filings in SEC EDGAR's recent list, going back to May 16, 2012. Its latest annual report, Form 10-KT, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on May 25.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Apr 3, 2025 | Feb 23, 2025 |
| 10-Q | Quarterly report | Jan 2, 2025 | Nov 24, 2024 |
| 10-Q | Quarterly report | Oct 4, 2024 | Aug 25, 2024 |
| 10-Q | Quarterly report | Aug 9, 2024 | Feb 25, 2024 |
| 10-Q | Quarterly report | Aug 9, 2024 | Nov 26, 2023 |
| 10-Q | Quarterly report | Aug 9, 2024 | Aug 27, 2023 |
| 10-Q | Quarterly report | Jun 2, 2023 | Feb 26, 2023 |
| 10-Q | Quarterly report | Mar 16, 2023 | Nov 27, 2022 |
| 10-Q/A | Amended quarterly report | Mar 16, 2023 | Aug 28, 2022 |
| 10-Q | Quarterly report | Oct 7, 2022 | Aug 28, 2022 |
| 10-Q | Quarterly report | Apr 7, 2022 | Feb 27, 2022 |
| 10-Q | Quarterly report | Jan 7, 2022 | Nov 28, 2021 |
| 10-Q | Quarterly report | Oct 5, 2021 | Aug 29, 2021 |
| 10-Q | Quarterly report | Apr 8, 2021 | Feb 28, 2021 |
| 10-Q | Quarterly report | Jan 7, 2021 | Nov 29, 2020 |
| 10-Q | Quarterly report | Oct 7, 2020 | Aug 30, 2020 |
| 10-Q | Quarterly report | Apr 3, 2020 | Feb 23, 2020 |
| 10-Q | Quarterly report | Jan 2, 2020 | Nov 24, 2019 |
| 10-Q | Quarterly report | Oct 3, 2019 | Aug 25, 2019 |
| 10-Q | Quarterly report | Apr 4, 2019 | Feb 24, 2019 |
| 10-Q | Quarterly report | Jan 7, 2019 | Nov 25, 2018 |
| 10-Q | Quarterly report | Oct 5, 2018 | Aug 26, 2018 |
| 10-Q | Quarterly report | Apr 5, 2018 | Feb 25, 2018 |
| 10-Q | Quarterly report | Jan 5, 2018 | Nov 26, 2017 |
| 10-Q | Quarterly report | Sep 28, 2017 | Aug 27, 2017 |
| 10-Q | Quarterly report | Apr 7, 2017 | Feb 26, 2017 |
| 10-Q | Quarterly report | Jan 5, 2017 | Nov 27, 2016 |
| 10-Q | Quarterly report | Sep 29, 2016 | Aug 28, 2016 |
| 10-Q | Quarterly report | Mar 30, 2016 | Feb 28, 2016 |
| 10-Q | Quarterly report | Jan 7, 2016 | Nov 29, 2015 |
| 10-Q | Quarterly report | Oct 1, 2015 | Aug 30, 2015 |
| 10-Q | Quarterly report | Apr 2, 2015 | Mar 1, 2015 |
| 10-Q | Quarterly report | Jan 9, 2015 | Nov 30, 2014 |
| 10-Q | Quarterly report | Oct 8, 2014 | Aug 31, 2014 |
| 10-Q | Quarterly report | Mar 28, 2014 | Feb 23, 2014 |
| 10-Q | Quarterly report | Jan 3, 2014 | Nov 24, 2013 |
| 10-Q | Quarterly report | Sep 26, 2013 | Aug 25, 2013 |
| 10-Q | Quarterly report | Apr 4, 2013 | Feb 24, 2013 |
| 10-Q | Quarterly report | Jan 4, 2013 | Nov 25, 2012 |
| 10-Q/A | Amended quarterly report | Jan 2, 2013 | Aug 26, 2012 |
| 10-Q | Quarterly report | Oct 3, 2012 | Aug 26, 2012 |
Showing 45 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LFCR (Nasdaq)
- Fiscal year ends
- May 25
- Incorporated in
- DE
- Headquarters
- Chaska, MN
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1005286
- Former names
- LANDEC CORP \CA\ (until Nov 7, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.